STOCK TITAN

Vanguard disaggregates holdings; Omnicell (NASDAQ: OMCL) shows 0% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed an amendment to its Schedule 13G/A reporting 0% beneficial ownership of Omnicell Inc. common stock. The filing states that, following an internal realignment on January 12, 2026, certain Vanguard subsidiaries and business divisions will report holdings separately in reliance on SEC Release No. 34-39538. The amendment, signed on March 27, 2026, lists 0 shares beneficially owned and 0% of the class, with no sole or shared voting or dispositive power.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings and now reports zero beneficial ownership in Omnicell.

The amendment records 0 shares and 0% ownership as of the filing, and cites an internal realignment on January 12, 2026 under SEC Release No. 34-39538. This indicates reporting responsibility shifted to subsidiaries or business divisions rather than a change in underlying investment strategy.

The practical effect is administrative: cash‑flow treatment and any subsidiary holdings are not described in this excerpt. Subsequent filings by the disaggregated entities may show actual positions; timing and amounts for those reports are not provided here.






68213N109

(CUSIP Number)
03/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What did The Vanguard Group report for OMCL in this Schedule 13G/A?

The filing reports 0 shares and 0% beneficial ownership of Omnicell common stock, with no voting or dispositive power. It states a reporting change after an internal realignment on January 12, 2026.

Why does Vanguard say it no longer has beneficial ownership over these Omnicell shares?

Vanguard cites an internal realignment on January 12, 2026 and reliance on SEC Release No. 34-39538, stating certain subsidiaries/business divisions will report holdings separately from The Vanguard Group, Inc.

Does this filing indicate Omnicell shares were sold by Vanguard?

No. The amendment documents reporting disaggregation and states 0 shares beneficially owned by The Vanguard Group; it does not describe sales, transfers, or cash proceeds in this excerpt.

Who signed the Schedule 13G/A amendment for Vanguard?

The form is signed by Ashley Grim, titled Head of Global Fund Administration, with a signature date of March 27, 2026.
Omnicell Com

NASDAQ:OMCL

View OMCL Stock Overview

OMCL Rankings

OMCL Latest News

OMCL Latest SEC Filings

OMCL Stock Data

1.60B
44.63M
Health Information Services
Electronic Computers
Link
United States
FORT WORTH